Trials / Terminated
TerminatedNCT02926872
Screening for Lysosomal Acid Lipase Deficiency
SCREENING FOR LYSOSOMAL ACID LIPASE DEFICIENCY AS THE UNDERLYING SOURCE OF HEPATIC INJURY IN PEDIATRIC PATIENTS WITH EVIDENCE OF ABNORMAL CLINICAL OR BIOCHEMICAL TESTS (DETECT)
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 22 (actual)
- Sponsor
- Alexion Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 2 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
The primary outcome of this study is the development of a clinical profile of pediatric patients with LAL-D, which will enable the Sponsor to provide more focused guidance to the medical community as to which pediatric patients should be tested for LAL-D.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | There is no intervention in the study |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2017-06-05
- Completion
- 2017-06-05
- First posted
- 2016-10-06
- Last updated
- 2017-06-16
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02926872. Inclusion in this directory is not an endorsement.